array biopharma leadership

All rights reserved. During his tenure, he also directed medicinal sciences, drug discovery and strategic alliances. All times are ET. "Array remains committed to its world-class discovery organization and its existing research partnerships. Cable News Network. 30 Array BioPharma reviews. and/or its affiliates. Company Reviews; Company Culture; Best Places to Work; 12 Companies That Will Pay You to Travel … Most stock quote data provided by BATS. Cable News Network. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. During this time, Array advanced 19 novel compounds into clinical trials, of which 14 remain in active development," said Ron Squarer, Chief Executive Officer of Array. During this time, Array advanced 19 novel compounds into clinical trials, of which 14 remain in active development," said Ron Squarer, Chief Executive Officer of Array. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Array BioPharma is a commercial stage biopharmaceutical company focused on the discovery, development and commercialization of targeted small … All Rights Reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN.

Array BioPharma Inc. is a fully integrated biopharmaceutical company focused on the discovery, development and commercialization of transformative and well-tolerated targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. "With several of these programs in late stage trials, and a strong management team in place, Array is well-positioned for continued success. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. BOULDER, Colo., Nov. 21, 2013 -- Array BioPharma Inc. (NASDAQ: ARRY) announced today that Kevin Koch, Ph.D., President and Chief Scientific Officer, will be leaving Array to pursue other opportunities. A free inside look at company reviews and salaries posted anonymously by employees. exclude terms. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

All rights reserved. Array BioPharma has 298 employees across 9 locations and $173.77 M in annual revenue in FY 2018. Dr. Saccomano obtained his Ph.D. in chemistry from Dr. Winkler developed expertise in drug development strategy and execution, clinical pharmacology, as well as planning regulatory strategy and leading successful negotiations with health authorities, through his 15 years of diverse global assignments in the biotech and pharmaceutical industries. As head of discovery technology, he managed and developed a diverse set of enabling technologies used broadly across the drug discovery pipeline. Bruce C. Cozadd co-founded Jazz Pharmaceuticals, Inc. in 2003 and has served as our Chairman and Chief Executive Officer since April 2009. and/or its affiliates. Array BioPharma is a U.S.-based, clinical stage, pharmaceutical company that focuses on oncology medication. A free inside look at company reviews and salaries posted anonymously by employees. In 1998, the company was founded by Drs. All Rights Reserved. All of the conditions of the offer have been satisfied and Pfizer and its subsidiary Arlington Acquisition Sub Inc. have accepted for payment for $48 per share in cash, without interest, subject to any required withholding taxes, all shares validly tendered and not validly withdrawn and will promptly pay for all such shares. BOULDER, Colo., May 19, 2014 /PRNewswire/ -- Array BioPharma Inc. , a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs... | … 15 Array BioPharma reviews in Boulder, CO. A free inside look at company reviews and salaries posted anonymously by employees. Array BioPharma's revenue is the ranked 2nd among it's top 10 competitors. Jobs; Company Reviews. Robert brings significant experience in advancing drugs through development, which will be key as we look to initiate a Phase 3 trial with our lead multiple myeloma program later this year. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. A free inside look at company reviews and salaries posted anonymously by employees. ""I am impressed with the consistent productivity of Array's discovery team, inventing approximately 18 drugs that have advanced into clinical development since the company's inception, as well as its impressive roster of alliance partners," said Dr. Saccomano. The top 10 competitors average 176. "Nick has a proven track record in drug discovery from his tenure at Pfizer as an executive and ultimately a Senior Vice President in R&D. Morningstar, Inc. All Rights Reserved. 30 Array BioPharma reviews. This information—including product information—is intended only for residents of the United States.

A WarnerMedia Company. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes.